These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29731738)

  • 21. Insulin-like growth factors in human breast cancer.
    Ellis MJ; Jenkins S; Hanfelt J; Redington ME; Taylor M; Leek R; Siddle K; Harris A
    Breast Cancer Res Treat; 1998; 52(1-3):175-84. PubMed ID: 10066081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
    Pivonello C; Negri M; De Martino MC; Napolitano M; de Angelis C; Provvisiero DP; Cuomo G; Auriemma RS; Simeoli C; Izzo F; Colao A; Hofland LJ; Pivonello R
    Oncotarget; 2016 Mar; 7(9):9718-31. PubMed ID: 26756219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis.
    Zhou Y; Zeng C; Li X; Wu PL; Yin L; Yu XL; Zhou YF; Xue Q
    J Mol Med (Berl); 2016 Aug; 94(8):887-97. PubMed ID: 26899323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors.
    Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR
    Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression levels of mRNA for insulin-like growth factors 1 and 2, IGF receptors and IGF binding proteins in in vivo and in vitro grown bovine follicles.
    Rebouças EL; Costa JJ; Passos MJ; Silva AW; Rossi RO; van den Hurk R; Silva JR
    Zygote; 2014 Nov; 22(4):521-32. PubMed ID: 23659735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA-binding protein IGF2BP3 targeting of oncogenic transcripts promotes hematopoietic progenitor proliferation.
    Palanichamy JK; Tran TM; Howard JM; Contreras JR; Fernando TR; Sterne-Weiler T; Katzman S; Toloue M; Yan W; Basso G; Pigazzi M; Sanford JR; Rao DS
    J Clin Invest; 2016 Apr; 126(4):1495-511. PubMed ID: 26974154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and functional characteristics of the human Arg59Ter insulin-like growth factor i receptor (IGF1R) mutation: implications for a gene dosage effect of the human IGF1R.
    Raile K; Klammt J; Schneider A; Keller A; Laue S; Smith R; Pfäffle R; Kratzsch J; Keller E; Kiess W
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2264-71. PubMed ID: 16569742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hypoxia on the expression of genes encoding insulin-like growth factors and some related proteins in U87 glioma cells without IRE1 function.
    Minchenko DO; Kharkova AP; Halkin OV; Karbovskyi LL; Minchenko OH
    Endocr Regul; 2016 Apr; 50(2):43-54. PubMed ID: 27560636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGF2 and IGF1R in pediatric adrenocortical tumors: roles in metastasis and steroidogenesis.
    Peixoto Lira RC; Fedatto PF; Marco Antonio DS; Leal LF; Martinelli CE; de Castro M; Tucci S; Neder L; Ramalho L; Seidinger AL; Cardinalli I; Mastellaro MJ; Yunes JA; Brandalise SR; Tone LG; Rauber Antonini SR; Scrideli CA
    Endocr Relat Cancer; 2016 Jun; 23(6):481-93. PubMed ID: 27185872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with insulin-like growth factor 1 receptor inhibitor reverses hypoxia-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Nurwidya F; Takahashi F; Kobayashi I; Murakami A; Kato M; Minakata K; Nara T; Hashimoto M; Yagishita S; Baskoro H; Hidayat M; Shimada N; Takahashi K
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):332-8. PubMed ID: 25446090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) promotes lung tumorigenesis via attenuating p53 stability.
    Zhao W; Lu D; Liu L; Cai J; Zhou Y; Yang Y; Zhang Y; Zhang J
    Oncotarget; 2017 Nov; 8(55):93672-93687. PubMed ID: 29212181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IGF2 increases de novo steroidogenesis in prostate cancer cells.
    Lubik AA; Gunter JH; Hollier BG; Ettinger S; Fazli L; Stylianou N; Hendy SC; Adomat HH; Gleave ME; Pollak M; Herington A; Nelson CC
    Endocr Relat Cancer; 2013 Apr; 20(2):173-86. PubMed ID: 23319492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
    Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
    Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas.
    Potratz JC; Saunders DN; Wai DH; Ng TL; McKinney SE; Carboni JM; Gottardis MM; Triche TJ; Jürgens H; Pollak MN; Aparicio SA; Sorensen PH
    Cancer Res; 2010 Nov; 70(21):8770-81. PubMed ID: 20959493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Let-7b Regulates Myoblast Proliferation by Inhibiting
    Lin S; Luo W; Ye Y; Bekele EJ; Nie Q; Li Y; Zhang X
    Front Physiol; 2017; 8():477. PubMed ID: 28736533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential regulation of igf1 and igf1r mRNA levels in the two hepatic lobes following intrauterine growth restriction and its treatment with intra-amniotic insulin-like growth factor-1 in ovine fetuses.
    Darp RA; de Boo HA; Phua HH; Oliver MH; Derraik JG; Harding JE; Bloomfield FH
    Reprod Fertil Dev; 2010; 22(8):1188-97. PubMed ID: 20883644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
    Niu J; Xu Z; Li XN; Han Z
    Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular vimentin interacts with insulin-like growth factor 1 receptor to promote axonal growth.
    Shigyo M; Kuboyama T; Sawai Y; Tada-Umezaki M; Tohda C
    Sci Rep; 2015 Jul; 5():12055. PubMed ID: 26170015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System.
    Vella V; Giuliano M; Nicolosi ML; Majorana MG; Marć MA; Muoio MG; Morrione A; Maggiolini M; Lappano R; De Francesco EM; Belfiore A
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.